United States v. Raymond Hunter

CourtCourt of Appeals for the Sixth Circuit
DecidedFebruary 3, 2021
Docket19-6464
StatusUnpublished

This text of United States v. Raymond Hunter (United States v. Raymond Hunter) is published on Counsel Stack Legal Research, covering Court of Appeals for the Sixth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Raymond Hunter, (6th Cir. 2021).

Opinion

NOT RECOMMENDED FOR PUBLICATION File Name: 21a0068n.06

No. 19-6464

UNITED STATES COURT OF APPEALS FOR THE SIXTH CIRCUIT FILED Feb 03, 2021 ) DEBORAH S. HUNT, Clerk UNITED STATES OF AMERICA, ) Plaintiff-Appellee, ) ON APPEAL FROM THE UNITED ) v. STATES DISTRICT COURT FOR ) THE EASTERN DISTRICT OF ) RAYMOND D. HUNTER, TENNESSEE ) Defendant-Appellant. ) OPINION )

BEFORE: BATCHELDER, STRANCH, and NALBANDIAN, Circuit Judges.

JANE B. STRANCH, Circuit Judge. Raymond D. Hunter is a person living with

schizophrenia whose symptoms can be effectively treated with medication. In 2019, he was

convicted of being a felon in possession of a firearm under 18 U.S.C. § 922(g)(1). Hunter

moved for a downward variance, citing his schizophrenia and its responsiveness to

pharmaceutical treatment as a mitigating factor. The district court denied his motion and

sentenced him to 78 months’ incarceration, in the middle of his Guidelines range. The Court

acknowledged that Hunter was unlikely to reoffend if he received treatment but then agreed with

the Government that “the only way we know we can protect the public is to put him in jail.”

Hunter now challenges the procedural reasonableness of his sentence, arguing that the

district court erred by relying on its prediction of the future symptoms of his schizophrenia to

increase his sentence. We AFFIRM. No. 19-6464, United States v. Hunter

I. BACKGROUND

A. Hunter’s Schizophrenia and Treatment

In 2008, when Hunter was in college, his schizophrenia began to manifest. He was

diagnosed and obtained mental health treatment at a local hospital.1 Prior to the onset of his

symptoms, Hunter was convicted of two misdemeanors, for possession of drug paraphernalia and

driving on a revoked license, and received suspended sentences and small fines for both. But

after his schizophrenia intensified, without medication, he was convicted of three robberies at

businesses in Chattanooga beginning in 2013. In the first, he used what was presumably a BB

gun to steal money and a car, but later returned valuable items that had not been in the car when

it was recovered; in the second, he again used a presumed BB gun to steal money. In the third,

which led to the arrest related to this case, he robbed two people of their cell phones at gunpoint

and then returned the phones after one chased and confronted him. In all three incidents, no one

was hurt. At sentencing in this case, Hunter’s counsel described the third robbery as a “weird,

weird scenario,” and the district court agreed that “there are some oddities about what [Hunter

was] doing.”

In November 2017, Hunter was arrested for the third robbery and was detained pretrial in

the Hamilton County Jail. Jail employees called the hospital’s crisis unit in April 2018 to attend

to him. Two days later, Hunter was ordered committed for a mental evaluation and transported

to the Federal Medical Center. Forensic psychologists there diagnosed him with “Unspecified

1 One common effect of schizophrenia is nonadherence to medication treatments. Dawn I. Velligan et al., Why Do Psychiatric Patients Stop Antipsychotic Medication? A Systematic Review of Reasons for Nonadherence to Medication in Patients with Serious Mental Illness, 11 Patient Preference & Adherence 449, 450–51 (2017) (reviewing 36 studies analyzing nonadherence, mostly “in patients with schizophrenia or schizophrenia-like disorders”). “Attitude toward medication is a complex and multidimensional variable.” Id. at 466; see also Peter M. Haddad et al., Nonadherence with Antipsychotic Medication in Schizophrenia: Challenges and Management Strategies, 5 Patient Related Outcome Measures 43, 49 (2014) (“Poor adherence cannot simply be regarded as ‘difficult’ behavior . . . ; rather, it can result from a range of factors that encompass the illness, medication, and organization of services, plus attributes of the clinician, patient, and caregivers. As a result, improving adherence often requires a range of interventions.”).

-2- No. 19-6464, United States v. Hunter

Schizophrenia Spectrum and Other Psychotic Disorder.” On the grounds the doctors identified,

Hunter’s counsel and the Government jointly moved the district court to find Hunter incompetent

to enter a plea or stand trial and to order him committed “for treatment for restoration to

competency” under 18 U.S.C. § 4241(d). The district court granted the motion. Hunter then

entered treatment at the FMC, where facility officials convened an administrative hearing and

decided to commence medication.

Over the next two months, Hunter was regularly given medication. After the injections,

“Hunter’s mental status improved significantly and was generally consistent for the remainder of

the evaluation period.”2 Ultimately, the forensic psychologists diagnosed Hunter with

schizophrenia “in full remission” as “currently treated with medication” and deemed him

competent to understand the nature and consequences of the proceedings against him.

B. Proceedings in the District Court

Hunter was transported back to the Eastern District of Tennessee, where he entered a

guilty plea on June 19, 2019. Prior to sentencing, the presentence report determined his

Guidelines range to be 70 to 87 months’ incarceration; neither Hunter nor the Government

disagreed. Hunter filed a motion asking the district court to vary downward from that range,

contending that because Hunter’s schizophrenia drove his criminal conduct, the fact that its

symptoms could be effectively treated by medication meant he was unlikely to reoffend. “[I]f

Mr. Hunter does not seek medication and treatment upon release,” the motion stated, “he will

almost surely reoffend.” But it also maintained that “no amount of jail time is going to ensure

that” Hunter would voluntarily seek that treatment, and asserted that “[t]he best method of

insuring medicine compliance is monitoring which can be done on supervised release.”

2 The effects of the medication typically take a week or two to appear and may take up to three months to achieve their full strength.

-3- No. 19-6464, United States v. Hunter

At sentencing, Hunter summarized the motion’s arguments, and the district court

reviewed the details of his prior convictions. The Government stated that it “certainly

sympathize[d] with [Hunter’s] plight,” and that Hunter’s counsel “ma[de] some good points

about medicated versus not medicated.” But, the Government continued, “[t]he problem is,

when [Hunter is] not medicated, he’s a danger,” and “the only way we know we can protect the

public is to put him in jail.” The Government then requested a sentence at the top of Hunter’s

Guidelines range.

The district court sentenced Hunter to 78 months’ incarceration, explaining its reasoning

as follows:

I have reviewed the documentation that . . . I’ve been provided in this case. I’ve looked at the motion . . . . I looked at the government’s response. I think you’re both right, I really do. I believe sincerely that . . . if we could somehow figure out the combination to have [Hunter] make better decisions about taking care of himself and his mental issues, that he wouldn’t be here today. But we haven’t figured out how to do that.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Robinson v. California
370 U.S. 660 (Supreme Court, 1962)
Gall v. United States
552 U.S. 38 (Supreme Court, 2007)
United States v. Savinon-Acosta
232 F.3d 265 (First Circuit, 2000)
United States v. Lamb
431 F. App'x 421 (Sixth Circuit, 2011)
United States v. John Tolbert, Jr.
459 F. App'x 541 (Sixth Circuit, 2012)
United States v. Larry Organek
65 F.3d 60 (Sixth Circuit, 1995)
United States v. Dewain Moses
106 F.3d 1273 (Sixth Circuit, 1997)
United States v. Henry A. Bostic
371 F.3d 865 (Sixth Circuit, 2004)
United States v. Aubrey Clark
469 F.3d 568 (Sixth Circuit, 2006)
United States v. Vonner
516 F.3d 382 (Sixth Circuit, 2008)
United States v. Simmons
587 F.3d 348 (Sixth Circuit, 2009)
United States v. Madden
515 F.3d 601 (Sixth Circuit, 2008)
United States v. Joe Head
748 F.3d 728 (Sixth Circuit, 2014)
United States v. Christopher Caper
571 F. App'x 456 (Sixth Circuit, 2014)
United States v. Anthony Van
541 F. App'x 592 (Sixth Circuit, 2013)
United States v. Khalil Abu Rayyan
885 F.3d 436 (Sixth Circuit, 2018)
United States v. Richard Parrish
915 F.3d 1043 (Sixth Circuit, 2019)
United States v. Cabrera
811 F.3d 801 (Sixth Circuit, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
United States v. Raymond Hunter, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-raymond-hunter-ca6-2021.